Presley Gerber posted about Ibogaine on Instagram while Marty Makary advised the FDA on drug approval potential amid an executive order fast-tracking psychedelic research.
1 report, 1 independent
Updated Fri 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Presley Gerber posted about Ibogaine on Instagram while Marty Makary advised the FDA on drug approval potential amid an executive order fast-tracking psychedelic research.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Presley Gerber
American model
Nothing else this week.
- FDA
-
Marty Makary
American surgeon and FDA Commissioner
Nothing else this week.
Related events
- Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
- Ohio and Pennsylvania regulate cannabis and kratom while the FDA advances government-funded clinical trials for ibogaine research.
- Arise is seeking FDA approval for a drug as of October 7, 2026.